This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Astrazeneca Ab, Dizal (Jiangsu) Pharmaceutical Co., Ltd., Cancer Research Technology Limited. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,534 
3 out of 15 
2 out of 269 Years Active: 2019-2025
Title: The Contributions of Attilla Kuan Tsuei Ting in Cancer Research
Introduction
Attilla Kuan Tsuei Ting, based in Cambridge, GB, is a distinguished inventor known for his significant contributions to the field of cancer research. With a total of six patents to his name, Attilla has made substantial strides in developing compounds that target critical mechanisms in cancer treatment.
Latest Patents
Two notable patents from Attilla include innovative compounds classified as Purinone and Triazolopyrimidine. The patent for Purinone compounds details their use in treating cancer, focusing on agents that interact with DNA-PK-mediated pathways. These compounds and their pharmaceutically acceptable salts play a crucial role in preventing and treating diseases, particularly cancer. His invention emphasizes the importance of such compounds in pharmaceutical compositions and the methods involved in their manufacture. Similarly, his Triazolopyrimidine compounds patent also addresses vital applications in cancer treatment, showcasing his commitment to advancing therapeutic options for this disease.
Career Highlights
Attilla's professional journey includes substantial roles in renowned organizations such as AstraZeneca and Cancer Research Technology Limited. His work in these companies has been pivotal in bridging theoretical research with practical applications, furthering the understanding and treatment of cancer.
Collaborations
Throughout his career, Attilla has collaborated with notable professionals in the field, including Frederick Woolf Goldberg and Maurice Raymond Verschoyle Finlay. These partnerships have facilitated innovative research efforts, contributing to the development of breakthrough therapies in cancer treatment.
Conclusion
Attilla Kuan Tsuei Ting's contributions to cancer research through his patents and collaborations illustrate his essential role in the ongoing battle against this disease. His innovative compounds provide hope for improved treatment options and underscore the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile